0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025
Published Date: May 2019
|
Report Code: QYRE-Auto-29O34
Home | Market Reports | Science | Biological Sciences
Global mRNA Cancer Vaccines and Therapeutics Market Size Status and Forecast 2019 2025

Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025

Code: QYRE-Auto-29O34
Report
May 2019
99 Pages
QYResearch
Region: Global, United States, Europe, China,
Description
Table of Content
Tables & Figures
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
In 2018, the global mRNA Cancer Vaccines and Therapeutics market size was 110 million US$ and it is expected to reach 610 million US$ by the end of 2025, with a CAGR of 24.1% during 2019-2025.

This report focuses on the global mRNA Cancer Vaccines and Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the mRNA Cancer Vaccines and Therapeutics development in United States, Europe and China.

The key players covered in this study
    Moderna Therapeutics
    CureVac
    Translate Bio
    BioNTech
    Sangamo Therapeutics
    Argos Therapeutics
    In-Cell-Art
    eTheRNA
    Ethris
    Tiba Biotechnology

Market segment by Type, the product can be split into
    Adeno Carcinomas
    Mucinous Carcinomas
    Adenosquamous Carcinomas

Market segment by Application, split into
    Infectious Disease
    Cancer
    Other

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global mRNA Cancer Vaccines and Therapeutics status, future forecast, growth opportunity, key market and key players.
    To present the mRNA Cancer Vaccines and Therapeutics development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of mRNA Cancer Vaccines and Therapeutics are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (2014-2025)
        1.4.2 Adeno Carcinomas
        1.4.3 Mucinous Carcinomas
        1.4.4 Adenosquamous Carcinomas
    1.5 Market by Application
        1.5.1 Global mRNA Cancer Vaccines and Therapeutics Market Share by Application (2014-2025)
        1.5.2 Infectious Disease
        1.5.3 Cancer
        1.5.4 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 mRNA Cancer Vaccines and Therapeutics Market Size
    2.2 mRNA Cancer Vaccines and Therapeutics Growth Trends by Regions
        2.2.1 mRNA Cancer Vaccines and Therapeutics Market Size by Regions (2014-2025)
        2.2.2 mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2014-2019)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 mRNA Cancer Vaccines and Therapeutics Market Size by Manufacturers
        3.1.1 Global mRNA Cancer Vaccines and Therapeutics Revenue by Manufacturers (2014-2019)
        3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Manufacturers (2014-2019)
        3.1.3 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
    3.2 mRNA Cancer Vaccines and Therapeutics Key Players Head office and Area Served
    3.3 Key Players mRNA Cancer Vaccines and Therapeutics Product/Solution/Service
    3.4 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2014-2019)
    4.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2014-2019)

5 United States
    5.1 United States mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
    5.2 mRNA Cancer Vaccines and Therapeutics Key Players in United States
    5.3 United States mRNA Cancer Vaccines and Therapeutics Market Size by Type
    5.4 United States mRNA Cancer Vaccines and Therapeutics Market Size by Application

6 Europe
    6.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
    6.2 mRNA Cancer Vaccines and Therapeutics Key Players in Europe
    6.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type
    6.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application

7 China
    7.1 China mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
    7.2 mRNA Cancer Vaccines and Therapeutics Key Players in China
    7.3 China mRNA Cancer Vaccines and Therapeutics Market Size by Type
    7.4 China mRNA Cancer Vaccines and Therapeutics Market Size by Application

8 Japan
    8.1 Japan mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
    8.2 mRNA Cancer Vaccines and Therapeutics Key Players in Japan
    8.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size by Type
    8.4 Japan mRNA Cancer Vaccines and Therapeutics Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
    9.2 mRNA Cancer Vaccines and Therapeutics Key Players in Southeast Asia
    9.3 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size by Type
    9.4 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size by Application

10 India
    10.1 India mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
    10.2 mRNA Cancer Vaccines and Therapeutics Key Players in India
    10.3 India mRNA Cancer Vaccines and Therapeutics Market Size by Type
    10.4 India mRNA Cancer Vaccines and Therapeutics Market Size by Application

11 Central & South America
    11.1 Central & South America mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
    11.2 mRNA Cancer Vaccines and Therapeutics Key Players in Central & South America
    11.3 Central & South America mRNA Cancer Vaccines and Therapeutics Market Size by Type
    11.4 Central & South America mRNA Cancer Vaccines and Therapeutics Market Size by Application

12 International Players Profiles
    12.1 Moderna Therapeutics
        12.1.1 Moderna Therapeutics Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 mRNA Cancer Vaccines and Therapeutics Introduction
        12.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
        12.1.5 Moderna Therapeutics Recent Development
    12.2 CureVac
        12.2.1 CureVac Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 mRNA Cancer Vaccines and Therapeutics Introduction
        12.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
        12.2.5 CureVac Recent Development
    12.3 Translate Bio
        12.3.1 Translate Bio Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 mRNA Cancer Vaccines and Therapeutics Introduction
        12.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
        12.3.5 Translate Bio Recent Development
    12.4 BioNTech
        12.4.1 BioNTech Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 mRNA Cancer Vaccines and Therapeutics Introduction
        12.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
        12.4.5 BioNTech Recent Development
    12.5 Sangamo Therapeutics
        12.5.1 Sangamo Therapeutics Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 mRNA Cancer Vaccines and Therapeutics Introduction
        12.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
        12.5.5 Sangamo Therapeutics Recent Development
    12.6 Argos Therapeutics
        12.6.1 Argos Therapeutics Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 mRNA Cancer Vaccines and Therapeutics Introduction
        12.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
        12.6.5 Argos Therapeutics Recent Development
    12.7 In-Cell-Art
        12.7.1 In-Cell-Art Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 mRNA Cancer Vaccines and Therapeutics Introduction
        12.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
        12.7.5 In-Cell-Art Recent Development
    12.8 eTheRNA
        12.8.1 eTheRNA Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 mRNA Cancer Vaccines and Therapeutics Introduction
        12.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
        12.8.5 eTheRNA Recent Development
    12.9 Ethris
        12.9.1 Ethris Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 mRNA Cancer Vaccines and Therapeutics Introduction
        12.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
        12.9.5 Ethris Recent Development
    12.10 Tiba Biotechnology
        12.10.1 Tiba Biotechnology Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 mRNA Cancer Vaccines and Therapeutics Introduction
        12.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
        12.10.5 Tiba Biotechnology Recent Development

13 Market Forecast 2019-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2019-2025)
    13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details
List of Tables and Figures

    Table mRNA Cancer Vaccines and Therapeutics Key Market Segments
    Table Key Players mRNA Cancer Vaccines and Therapeutics Covered
    Table Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type 2014-2025
    Figure Adeno Carcinomas Figures
    Table Key Players of Adeno Carcinomas
    Figure Mucinous Carcinomas Figures
    Table Key Players of Mucinous Carcinomas
    Figure Adenosquamous Carcinomas Figures
    Table Key Players of Adenosquamous Carcinomas
    Table Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
    Figure Infectious Disease Case Studies
    Figure Cancer Case Studies
    Figure Other Case Studies
    Figure mRNA Cancer Vaccines and Therapeutics Report Years Considered
    Table Global mRNA Cancer Vaccines and Therapeutics Market Size 2014-2025 (Million US$)
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
    Table Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions 2014-2025 (Million US$)
    Table Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions 2014-2019 (Million US$)
    Table Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions 2014-2019
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions 2014-2019
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions 2019
    Table Market Top Trends
    Table Global mRNA Cancer Vaccines and Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
    Table Global mRNA Cancer Vaccines and Therapeutics Market Share by Manufacturers (2014-2019)
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Share by Manufacturers in 2018
    Table Global mRNA Cancer Vaccines and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players mRNA Cancer Vaccines and Therapeutics Product/Solution/Service
    Table Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2014-2019) (Million US$)
    Table Global mRNA Cancer Vaccines and Therapeutics Market Size Share by Type (2014-2019)
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2014-2019)
    Table Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2014-2019) (Million US$)
    Table Global mRNA Cancer Vaccines and Therapeutics Market Size Share by Application (2014-2019)
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2014-2019)
    Figure Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application in 2018
    Figure United States mRNA Cancer Vaccines and Therapeutics Market Size 2014-2019 (Million US$)
    Table United States Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2018-2019) (Million US$)
    Table United States Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2018-2019)
    Table United States mRNA Cancer Vaccines and Therapeutics Market Size by Type (2014-2019) (Million US$)
    Table United States mRNA Cancer Vaccines and Therapeutics Market Share by Type (2014-2019)
    Table United States mRNA Cancer Vaccines and Therapeutics Market Size by Application (2014-2019) (Million US$)
    Table United States mRNA Cancer Vaccines and Therapeutics Market Share by Application (2014-2019)
    Figure Europe mRNA Cancer Vaccines and Therapeutics Market Size 2014-2019 (Million US$)
    Table Europe Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2018-2019) (Million US$)
    Table Europe Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2018-2019)
    Table Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2014-2019) (Million US$)
    Table Europe mRNA Cancer Vaccines and Therapeutics Market Share by Type (2014-2019)
    Table Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2014-2019) (Million US$)
    Table Europe mRNA Cancer Vaccines and Therapeutics Market Share by Application (2014-2019)
    Figure China mRNA Cancer Vaccines and Therapeutics Market Size 2014-2019 (Million US$)
    Table China Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2018-2019) (Million US$)
    Table China Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2018-2019)
    Table China mRNA Cancer Vaccines and Therapeutics Market Size by Type (2014-20189) (Million US$)
    Table China mRNA Cancer Vaccines and Therapeutics Market Share by Type (2014-2019)
    Table China mRNA Cancer Vaccines and Therapeutics Market Size by Application (2014-2019) (Million US$)
    Table China mRNA Cancer Vaccines and Therapeutics Market Share by Application (2014-2019)
    Figure Japan mRNA Cancer Vaccines and Therapeutics Market Size 2014-2019 (Million US$)
    Table Japan Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2018-2019) (Million US$)
    Table Japan Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2018-2019)
    Table Japan mRNA Cancer Vaccines and Therapeutics Market Size by Type (2014-2019) (Million US$)
    Table Japan mRNA Cancer Vaccines and Therapeutics Market Share by Type (2014-2019)
    Table Japan mRNA Cancer Vaccines and Therapeutics Market Size by Application (2014-2019) (Million US$)
    Table Japan mRNA Cancer Vaccines and Therapeutics Market Share by Application (2014-2019)
    Figure Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size 2014-2019 (Million US$)
    Table Southeast Asia Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2018-2019) (Million US$)
    Table Southeast Asia Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2018-2019)
    Table Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size by Type (2014-2019) (Million US$)
    Table Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Share by Type (2014-2019)
    Table Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size by Application (2014-2019) (Million US$)
    Table Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Share by Application (2014-2019)
    Figure India mRNA Cancer Vaccines and Therapeutics Market Size 2014-2019 (Million US$)
    Table India Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2018-2019) (Million US$)
    Table India Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2018-2019)
    Table India mRNA Cancer Vaccines and Therapeutics Market Size by Type (2014-2019) (Million US$)
    Table India mRNA Cancer Vaccines and Therapeutics Market Share by Type (2014-2019)
    Table India mRNA Cancer Vaccines and Therapeutics Market Size by Application (2014-2019) (Million US$)
    Table India mRNA Cancer Vaccines and Therapeutics Market Share by Application (2014-2019)
    Figure Central & South America mRNA Cancer Vaccines and Therapeutics Market Size 2014-2019 (Million US$)
    Table Central & South America Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2018-2019) (Million US$)
    Table Central & South America Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2018-2019)
    Table Central & South America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2014-2019) (Million US$)
    Table Central & South America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2014-2019)
    Table Central & South America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2014-2019) (Million US$)
    Table Central & South America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2014-2019)
    Table Moderna Therapeutics Company Details
    Table Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019) (Million US$)
    Figure Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
    Table Moderna Therapeutics Recent Development
    Table CureVac Company Details
    Table CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)(Million US$)
    Figure CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
    Table CureVac Recent Development
    Table Translate Bio Company Details
    Table Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)(Million US$)
    Figure Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
    Table Translate Bio Recent Development
    Table BioNTech Company Details
    Table BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)(Million US$)
    Figure BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
    Table BioNTech Recent Development
    Table Sangamo Therapeutics Company Details
    Table Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)(Million US$)
    Figure Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
    Table Sangamo Therapeutics Recent Development
    Table Argos Therapeutics Company Details
    Table Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)(Million US$)
    Figure Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
    Table Argos Therapeutics Recent Development
    Table In-Cell-Art Company Details
    Table In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)(Million US$)
    Figure In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
    Table In-Cell-Art Recent Development
    Table eTheRNA Company Details
    Table eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)(Million US$)
    Figure eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
    Table eTheRNA Recent Development
    Table Ethris Company Details
    Table Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)(Million US$)
    Figure Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
    Table Ethris Recent Development
    Table Tiba Biotechnology Company Details
    Table Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)(Million US$)
    Figure Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
    Table Tiba Biotechnology Recent Development
    Table Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions (Million US$) 2019-2025
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Size Share by Regions (2019-2025)
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Size Share by Regions in 2025
    Figure United States mRNA Cancer Vaccines and Therapeutics Market Size Forecast (2019-2025)(Million USD)
    Figure Europe mRNA Cancer Vaccines and Therapeutics Market Size Forecast (2019-2025)(Million USD)
    Figure China mRNA Cancer Vaccines and Therapeutics Market Size Forecast (2019-2025)(Million USD)
    Figure Japan mRNA Cancer Vaccines and Therapeutics Market Size Forecast (2019-2025)(Million USD)
    Figure Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size Forecast (2019-2025)(Million USD)
    Figure India mRNA Cancer Vaccines and Therapeutics Market Size Forecast (2019-2025)(Million USD)
    Figure Central & South America mRNA Cancer Vaccines and Therapeutics Market Size Forecast (2019-2025)(Million USD)
    Table Global mRNA Cancer Vaccines and Therapeutics Market Size by Product (2019-2025) (Million US$)
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Size by Product (2019-2025)
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Size by Product in 2025
    Table Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2025) (Million US$)
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2025)
    Figure Global mRNA Cancer Vaccines and Therapeutics Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Insect Cell Culture Medium Market Research Report 2022
Global Insect Cell Culture Medium Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-35A11450
Thu Aug 11 00:00:00 UTC 2022

Add to Cart

Global Cortical Grid Electrodes Market Research Report 2022
Global Cortical Grid Electrodes Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-17U11756
Thu Aug 11 00:00:00 UTC 2022

Add to Cart

Global Cysteine Protease Market Research Report 2022
Global Cysteine Protease Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-30L11388
Thu Aug 11 00:00:00 UTC 2022

Add to Cart

Global and Japan Brefeldin A Market Insights Forecast to 2027
Global Brefeldin A Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-16B8424
Wed Aug 10 00:00:00 UTC 2022

Add to Cart